Acusphere, Inc (ACUS)

[stark12]

(EMEA/H/C/002347), (perflubutane),
(ultrasound imaging agent indicated for the
detection of coronary artery disease (CAD))
List of Outstanding Issues adopted on
22.05.2014, 20.03.2014, 21.11.2013.
List of Questions adopted on 21.02.2013.
• Report from SAG CVS meeting held on 7
July 2014: For discussion
Possible oral explanation to be held on Monday 21
July 2014 at 16.30 pm.

If I read this correctly, there may have been an oral explanation on July 21st. I guess we have to wait until the July minutes come out to see if the oral explanation occurred and what the content was.